Medartis Holding AG Cash Flow Conversion Efficiency
Medartis Holding AG cash flow conversion efficiency. Based on the latest financial reports, Medartis Holding AG (MED) has a cash flow conversion efficiency ratio of 0.019x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF5.30 Million ≈ $6.70 Million USD) by net assets (CHF281.87 Million ≈ $356.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Medartis Holding AG (2015–2025)
Cash flow conversion efficiency of Medartis Holding AG from 2015 to 2025. This chart illustrates how Medartis Holding AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Medartis Holding AG (MED) stock price for real-time trading data and today's change.
Medartis Holding AG Cash Flow Conversion Ratio Explained
Medartis Holding AG cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Medartis Holding AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medartis Holding AG ranked by their cash flow conversion efficiency. Also see MED market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Evergreen Steel Corp
TW:2211
|
0.006x |
|
Taiyuan Heavy Industry Co Ltd
SHG:600169
|
0.080x |
|
Ituran Location and Control Ltd
NASDAQ:ITRN
|
0.143x |
|
Sri Trang Agro-Industry Public Company Limited
BK:STA
|
-0.079x |
|
Arcadyan Technology Corp
TW:3596
|
-0.503x |
|
MYT Netherlands Parent BV
NYSE:MYTE
|
0.045x |
|
Eerly Govt Ppty Inc
NYSE:DEA
|
0.020x |
|
Shanxi Sanwei Group Co Ltd
SHE:000755
|
0.066x |
Annual Cash Flow Conversion Efficiency for Medartis Holding AG (2015–2025)
The table below shows the annual cash flow conversion efficiency of Medartis Holding AG from 2015 to 2025. Review Medartis Holding AG free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CHF275.87 Million ≈ $348.78 Million |
CHF34.82 Million ≈ $44.02 Million |
0.126x | +6.11% |
| 2024-12-31 | CHF269.65 Million ≈ $340.91 Million |
CHF32.07 Million ≈ $40.55 Million |
0.119x | +51.78% |
| 2023-12-31 | CHF254.96 Million ≈ $322.34 Million |
CHF19.98 Million ≈ $25.26 Million |
0.078x | +574.45% |
| 2022-12-31 | CHF237.78 Million ≈ $300.62 Million |
CHF-3.93 Million ≈ $-4.97 Million |
-0.017x | -117.66% |
| 2021-12-31 | CHF224.00 Million ≈ $283.19 Million |
CHF20.95 Million ≈ $26.49 Million |
0.094x | +58.02% |
| 2020-12-31 | CHF213.04 Million ≈ $269.33 Million |
CHF12.61 Million ≈ $15.94 Million |
0.059x | +57.27% |
| 2019-12-31 | CHF215.57 Million ≈ $272.54 Million |
CHF8.11 Million ≈ $10.26 Million |
0.038x | +27.36% |
| 2018-12-31 | CHF218.23 Million ≈ $275.91 Million |
CHF6.45 Million ≈ $8.15 Million |
0.030x | -95.43% |
| 2017-12-31 | CHF17.04 Million ≈ $21.54 Million |
CHF11.01 Million ≈ $13.92 Million |
0.646x | -7.16% |
| 2016-12-31 | CHF17.10 Million ≈ $21.62 Million |
CHF11.91 Million ≈ $15.06 Million |
0.696x | +375.23% |
| 2015-12-31 | CHF-46.95 Million ≈ $-59.36 Million |
CHF11.88 Million ≈ $15.02 Million |
-0.253x | -- |
About Medartis Holding AG
Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company's medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, a… Read more